Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03920397Completed
Open-label trial in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Federal University of Rio de Janeiro. Primary endpoints: Peak response of C-peptide after mixed meal test at 24 months and Glycated hemoglobin at 24 months. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03920397.